Article

BVI device helps intraop small pupil management

Beaver Visitec International (BVI) introduces its new Visitec I-Ring Pupil Expander,a single-use iris retraction device for intraoperative small pupil management.

Beaver Visitec International (BVI) introduces its new Visitec I-Ring Pupil Expander, a single-use iris retraction device for intraoperative small pupil management.

The device is designed to safely expand the iris to increase the surgeon's field of view and improve access to the lens of the eye while protecting the iris. 

“We are excited to bring the latest innovation in intraoperative small pupil management to market,” said Tom Kapfer, president and chief executive officer of BVI. “The [device] is a simple, safe, and innovative solution that helps maintain an optimal field of view during ophthalmic surgery without compromising intraocular tissue safety.”

The device is made of soft, resilient polyurethane material that is gentle on intraocular tissue. Insertion, engagement, and removal are single-handed. The fixed channel height prevents pinching of the iris during the insertion and removal steps, and safe positioning holes further protect the iris from potential damage.

 

Complete (360°) engagement with the iris provides consistent pupil expansion without distortion. The uniform field of view is 6.3 mm, with an aperture shape that helps guide the capsulorhexis. Overall, the learning curve for the surgical team is minimal.

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.